Trademark Attorney / Law Firm

Willliam S. Frommer – Trademark Portfolio

Willliam S. Frommer specializes in Class 5 (Pharmaceuticals) trademark filings before the United States Patent and Trademark Office (USPTO), with 2 of 2 total filings concentrated in this category. The practice also covers Class 42 (Computer & Scientific) along with 4 other Nice Classification classes. Currently, 0 trademarks are registered.

2 Total Trademarks
Loading...
By Date
By Name
Filter by Class:

SU
SU
Cancelled 2008
HYATE:C
HYATE:C
Cancelled 2007

Practice Areas by Trademark Class

Willliam S. Frommer's trademark practice covers 4 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademark applications has Willliam S. Frommer filed?

Willliam S. Frommer has filed 2 trademark applications with the United States Patent and Trademark Office (USPTO).

What trademark classes does Willliam S. Frommer specialize in?

Willliam S. Frommer has filed trademarks across 4 Nice Classification classes. The most common practice areas include Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is Willliam S. Frommer's trademark registration success rate?

Willliam S. Frommer has a 0% trademark registration rate, with 0 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.